Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 6, 2004. The report serves as a notification of changes in directors' interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is limited to reporting specific share transactions and does not contain financial performance data.
Material Changes
On October 5, 2004, Abacus (GSK) Trustees Limited, acting as trustee for the GlaxoSmithKline Employee Trust ("GSK Trust"), transferred 10,228 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991. The company was advised of this transaction on October 6, 2004.
Management Commentary and Risks
The GSK Trust is a discretionary trust where all current and former employees of GlaxoSmithKline plc and its subsidiaries are potential beneficiaries. Three directors—Dr. J-P Garnier, Dr. T Yamada, and Mr. J D Coombe—are noted as having an interest in the shares held within the GSK Trust in the same capacity as other employees. No other risks, contingencies, or unusual items are disclosed in this filing.
Investor Verification Points
- Verify the total number of shares held by the GSK Trust prior to the transfer of 10,228 shares.
- Confirm the specific allocation of the transferred shares among the three named directors versus other plan participants.
- Review the full terms of the SmithKline Beecham Employee Share Option Plan 1991 to understand vesting conditions.